ISENTRESS (NuCare Pharmaceuticals,Inc.)
Welcome to the PulseAid listing for the ISENTRESS drug offered from NuCare Pharmaceuticals,Inc.. This HIV Integrase Inhibitors [MoA],Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | NuCare Pharmaceuticals,Inc. |
| NON-PROPRIETARY NAME: | RALTEGRAVIR |
| SUBSTANCE NAME: | RALTEGRAVIR POTASSIUM |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | HIV Integrase Inhibitors [MoA],Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2007-10-12 |
| END MARKETING DATE: | 0000-00-00 |
ISENTRESS HUMAN PRESCRIPTION DRUG Details:
| Item Description | ISENTRESS from NuCare Pharmaceuticals,Inc. |
| LABELER NAME: | NuCare Pharmaceuticals,Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 400(mg/1) |
| START MARKETING DATE: | 2007-10-12 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 68071-2113_46ef8e2e-ae64-6a3c-e054-00144ff8d46c |
| PRODUCT NDC: | 68071-2113 |
| APPLICATION NUMBER: | NDA022145 |
Other RALTEGRAVIR POTASSIUM Pharmaceutical Manufacturers / Labelers:
